Google to invest record $15 billion in AI infrastructure in the ‘Texas of Europe’
Google on Wednesday said it would invest $15.1 billion into AI infrastructure in Finland, marking the tech giant’s largest single investment in Europe.
‘This is not a joke’: Iceland condemns Trump’s post showing island under American flag
Denmark and Mexico also objected, underscoring the diplomatic backlash to Trump’s territorial ambitions.
Experts weigh in as researcher says AI has more than 10% chance of ‘killing all humans’
Jacob Coxon said in a post on X that Anthropic and OpenAI are “gambling with our lives.”
Chipotle’s new restaurant in a hip Seoul neighborhood tests its Asian expansion strategy
Chipotle is making its Asia debut in South Korea through its first-ever joint venture for international expansion, with Singapore next in 2027.
Meta pushes into personal AI agents as company faces public reckoning over privacy and safety
Meta unveiled its Muse personal agent app that comes in a free tier or a monthly subscription costing $20 or $100 depending on usage.
Why the Fed’s interest rate call could come down to a few hundredths of a percentage point
As markets vacillate between which way they see policymakers leaning, all eyes will turn to economic reports measuring producer and consumer prices.
New Hampshire picks Pappas and Sununu in primary for key open Senate seat
Incumbent Sen. Jeanne Shaheen, D-N.H., will retire when her term ends in January.
U.S. sanctions Iranian airlines in aim to tighten economic squeeze as war spreads, oil rises
The latest U.S. action under “Operation Economic Outcast” targets all Iranian airlines that were not already facing sanctions.
Here’s where rental demand is heading and what it means for future home sales
As U.S. rent prices rise, more tenants are relocating to cheaper markets, according to a new report by Zillow.
AstraZeneca’s COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes
The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca’s peak annual sales forecast of more than $5 billion.
